These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25635718)

  • 1. Immunity unmasks APOL1 in collapsing glomerulopathy.
    McNicholas BA; Nelson PJ
    Kidney Int; 2015 Feb; 87(2):270-2. PubMed ID: 25635718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular disease: innate immunity-APOL1 interaction.
    Sidaway P
    Nat Rev Nephrol; 2014 Oct; 10(10):543. PubMed ID: 25157835
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.
    Larsen CP; Freedman BI
    J Am Soc Nephrol; 2015 Jun; 26(6):1232-5. PubMed ID: 25573910
    [No Abstract]   [Full Text] [Related]  

  • 4. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.
    Nichols B; Jog P; Lee JH; Blackler D; Wilmot M; D'Agati V; Markowitz G; Kopp JB; Alper SL; Pollak MR; Friedman DJ
    Kidney Int; 2015 Feb; 87(2):332-42. PubMed ID: 25100047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.
    Kopp JB; Winkler CA; Zhao X; Radeva MK; Gassman JJ; D'Agati VD; Nast CC; Wei C; Reiser J; Guay-Woodford LM; Pollak MR; Hildebrandt F; Moxey-Mims M; Gipson DS; Trachtman H; Friedman AL; Kaskel FJ;
    J Am Soc Nephrol; 2015 Jun; 26(6):1443-8. PubMed ID: 25573908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.
    Larsen CP; Beggs ML; Saeed M; Walker PD
    J Am Soc Nephrol; 2013 Apr; 24(5):722-5. PubMed ID: 23520206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
    Abid Q; Best Rocha A; Larsen CP; Schulert G; Marsh R; Yasin S; Patty-Resk C; Valentini RP; Adams M; Baracco R
    Am J Kidney Dis; 2020 Feb; 75(2):287-290. PubMed ID: 31601430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular Effects of Age and APOL1.
    Meyer TW; Lenihan CR
    J Am Soc Nephrol; 2015 Dec; 26(12):2901-3. PubMed ID: 26038527
    [No Abstract]   [Full Text] [Related]  

  • 9. Editing of APOL1 mRNA reduces APOL1 expression and activation of innate immunity.
    Karttunen H; Ross MJ
    Kidney Int; 2023 Aug; 104(2):230-233. PubMed ID: 37224919
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial focal segmental glomerulosclerosis (FSGS) in a Nigerian family and exclusion of mutations in NPHS2,WT1 and APOL1.
    Anochie IC; Eke FU; Okpere AN
    West Afr J Med; 2012; 31(4):273-6. PubMed ID: 23468032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics. Kidney disease is parasite-slaying protein's downside.
    Leslie M
    Science; 2010 Jul; 329(5989):263. PubMed ID: 20647431
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial FSGS.
    Pollak MR
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):422-5. PubMed ID: 25168831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collapsing Glomerulopathy.
    Koirala A; Akilesh S; Jefferson JA
    Adv Kidney Dis Health; 2024 Jul; 31(4):290-298. PubMed ID: 39084754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle.
    Hays T; Wyatt CM
    Kidney Int; 2012 Aug; 82(3):259-60. PubMed ID: 22791322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.
    Mikulak J; Oriolo F; Portale F; Tentorio P; Lan X; Saleem MA; Skorecki K; Singhal PC; Mavilio D
    Retrovirology; 2016 Sep; 13(1):63. PubMed ID: 27599995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOL1 nephropathy: from gene to mechanisms of kidney injury.
    Kruzel-Davila E; Wasser WG; Aviram S; Skorecki K
    Nephrol Dial Transplant; 2016 Mar; 31(3):349-58. PubMed ID: 25561578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.
    Ulasi II; Tzur S; Wasser WG; Shemer R; Kruzel E; Feigin E; Ijoma CK; Onodugo OD; Okoye JU; Arodiwe EB; Ifebunandu NA; Chukwuka CJ; Onyedum CC; Ijoma UN; Nna E; Onuigbo M; Rosset S; Skorecki K
    Nephron Clin Pract; 2013; 123(1-2):123-8. PubMed ID: 23860441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
    Behar DM; Kedem E; Rosset S; Haileselassie Y; Tzur S; Kra-Oz Z; Wasser WG; Shenhar Y; Shahar E; Hassoun G; Maor C; Wolday D; Pollack S; Skorecki K
    Am J Nephrol; 2011; 34(5):452-9. PubMed ID: 21968148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
    Bruggeman LA; Wu Z; Luo L; Madhavan SM; Konieczkowski M; Drawz PE; Thomas DB; Barisoni L; Sedor JR; O'Toole JF
    J Am Soc Nephrol; 2016 Dec; 27(12):3600-3610. PubMed ID: 27026370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular dialogue between African trypanosomes and humans].
    Pays E
    Bull Mem Acad R Med Belg; 2011; 166(10-12):358-63; discussion 364-5. PubMed ID: 23082501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.